written on 04.04.2014

Novartis fighting two-pronged legal battle in India on Galvus patent

TAGS: ,

Novartis, already in a legal battle to try to keep India's Wockhardt from launching a generic of its diabetes blockbuster Galvus, says it is now trying to prevent Biocon from doing the same thing.